CIK 0001314052 · Large accelerated filer<br>Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 980608404
- Phone
- 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-06 | FAVUS ELLIOT Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-01-06 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-01-06 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-06-04 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2019-05-03 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2018-10-01 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2018-10-01 | FAVUS ELLIOT Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2018-10-01 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2018-10-01 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +409,500 | 409,500 | ||
| 2018-10-01 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2018-10-01 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +27,300 | 27,300 | ||
| 2018-10-01 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2018-05-15 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-05-15 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2018-03-07 | MISSLING CHRISTOPHER U President and CEO | Purchase | +1,360 | $2.92 | $4K | 1,018,210 |
| 2018-03-06 | MISSLING CHRISTOPHER U President and CEO | Purchase | +1,450 | $2.73 | $4K | 1,016,850 |
| 2018-03-05 | MISSLING CHRISTOPHER U President and CEO | Purchase | +1,500 | $2.63 | $4K | 1,015,400 |
| 2018-03-02 | MISSLING CHRISTOPHER U Director, President & CEO | Purchase | +1,650 | $2.41 | $4K | 1,013,900 |
| 2017-12-13 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2017-12-13 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 |
Page 7 of 12 · 232 trades